Is the DoorDash IPO Overvalued?
DoorDash entered the market with a bang on Wednesday in its initial public offering.
All Work
Chris Lange
Is Cardtronics Getting Enough From This Acquisition Offer?
Cardtronics was one of the biggest movers on Wednesday after the company confirmed that it received an offer to be bought out.
The Hits Keep Coming With Curis’s Secondary Offering
Curis shares are on the run again. This time it’s due to a secondary offering.
GameStop Is Cautiously Optimistic Despite Earnings Flop
GameStop reported its most recent quarterly results after the markets closed on Tuesday.
QuantumScape’s Lithium Batteries Could Be a Gamechanger
QuantumScape stock jumped on Tuesday after the firm released performance data for its tech regarding its next-generation solid-state lithium-metal batteries for use in electric vehicles.
This Curis Cancer Study Is a Big Hit
Curis has announced preliminary data from its ongoing early-stage study in patients with acute myeloid leukemia or high-risk myelodysplastic syndromes.
The Earnings Surprise at Stitch Fix May Not Have Been the Biggest News
Stitch Fix reported a big earnings surprise after the close bell on Monday, and a huge addition to management.
Is Kodak Now a Stock to Buy After Being Cleared of ‘Wrongdoing’?
Kodak has been a favorite for retail traders lately, with its massive volume and even greater swings. This stock received a resounding vote of confidence from traders on Monday in regards to its “suspect”…
Is the FDA’s CRL on scPharma Justified?
After scPhamaceuticals announced that it had received a Complete Response Letter from the FDA, its shares were absolutely crushed on Monday.
GameStop, Campbell Soup, Stitch Fix, Broadcom, Costco, and More Major Earnings Coming This Week
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports expected this week.
Why Domo Is Friday’s Big Earnings Winner
Cloud software company Domo reported better than expected third-quarter financial results after the closing bell on Thursday.
Sutro Bio’s Ovarian Cancer Treatment Ready for the Next Level
Sutro Biopharma made a huge gain to close out the week after the firm provided an update from its ongoing dose-escalation in its ovarian cancer trial.
Carnival Doubles Down on Cancellations
Carnival, along with the rest of the cruise industry, has been one of the biggest losers from the coronavirus.
Zscaler Strikes Back With Q1 Earnings
Zscaler stock popped early Thursday after it reported better than expected quarterly results late on Wednesday.
COVID-19 Vaccines Are on the Way and Major Players Are Cashing In
COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.
Should Investors Be More Cautious on Lyft After Updated Q4 Guidance?
Lyft shares made a handy gain on Wednesday after the company announced an update to its fourth-quarter outlook.
Vanda Investors Can Sleep Easy With This FDA Approval
Vanda Pharma shares jumped on Wednesday after the company announced an update from the FDA regarding its treatment for nighttime sleep disturbances associated with Smith-Magenis syndrome.
Salesforce Earnings Aren’t Even The Biggest Mover For This Stock
Salesforce released its most recent quarterly results after the close and confirmed that it would be acquiring Slack.
BlackBerry’s Amazon Partnership Could Be Huge
BlackBerry shares shot up on Tuesday after the company announced a deal with Amazon. Ultimately, the deal is to develop and market BlackBerry's Intelligent Vehicle Data Platform, IVY
Why Zoom Video’s Incredible Third Quarter Might Not Be Enough For Investors
Zoom's numbers this quarter were incredible but after a few back-to-back-to-back quarters of earthshattering numbers, investors may be facing buyers fatigue.